Latest Ratings for CME
DateFirmActionFromTo Mar 2022RosenblattMaintainsNeutral Mar 2022UBSMaintainsBuy Mar 2022Credit SuisseMaintainsNeutral
DateFirmActionFromTo Mar 2022RosenblattMaintainsNeutral Mar 2022UBSMaintainsBuy Mar 2022Credit SuisseMaintainsNeutral